Acquisition Activity and Portfolio Growth
Acquired 6 healthcare facilities in 2025 for an aggregate purchase price of approximately $150 million (241,000 rentable sq ft); closed an additional inpatient rehabilitation facility in Oklahoma City after year-end for $43.1 million (facility expanded from 40 to 58 licensed beds).
Strong Liquidity and Conservative Leverage
Total liquidity exceeded $480 million at year-end; net debt to EBITDAre of 3.9x, below the company's target leverage range of 4.5x–5.5x, translating to over $200 million of debt capacity to reach the midpoint and theoretical incremental buying capacity of ~$225 million (midpoint) to ~$375 million (high end).
Cash NOI and Same-Store Performance
Cash NOI for the year was $169.9 million versus $168.6 million in 2024, a +0.8% increase driven by acquisitions and same-store cash NOI growth of +0.9%. Excluding certain one-time fees, cash NOI growth would have been +4.4% and same-store cash NOI +1.1%.
FFO per Share Growth
FFO per share for the full year was $2.16, a +3.6% increase year-over-year, supported by straight-line rent increases, higher interest income on mezzanine loans, and reduced G&A/onetime listing costs in the prior year.
Tenant Credit Quality and Coverage Improvement
Investment-grade tenant/guarantor percentage increased by 2.3 percentage points year-over-year to 40.6%. Portfolio-wide EBITDARM rent coverage improved to 5.9x in 2025 from 5.3x in 2024 (5.7x excluding an outsized Saginaw tenant) and 75.6% of ABR now reports financials at tenant or guarantor level.
Portfolio Optimization and Redevelopment Activity
Completed over $7 million of redevelopment projects in 2025 with compelling risk-adjusted returns and expects additional expansion opportunities (management noted these expansions often yield 150–200 bps higher than going-in cap rates). Executed planned dispositions (Saginaw sale closed for $14.5 million; Henderson and Las Vegas II expected to close in Q1 2026; Alexandria sale under contract).
Longer Lease Term and High Retention
Weighted average remaining lease term increased from 9.7 years to 10.0 years by year-end. Of the 4.8% of GLA scheduled to expire in 2025, the company retained 90% of expiring tenancy by square footage, and non-renewals represented only 0.5% of ABR.
Institutional Recognition and Market Position
Company was added to prominent equity indices (including RMZ and Russell 2000), and shareholder base rotated materially toward institutional investors (management noted roughly 70% institutional ownership), reflecting stronger market recognition.